SPEAKERS

SPEAKERS

Location: Aud I, Teorifagbygget (TEO-H1)
Location: B 1005, HSL-building (close to registration)
Eirik W. Lundblad, Director
UiT Arctic University of Norway

Presentation: Biotech as Business Workshop Introduction

Eirik Wasmuth Lundblad is CEO of the Arctic Biodiscovery Centre, UiT The Arctic University of Norway, where he is responsible for the activity within marine bioprospecting – the hunt for new molecules from the sea. Eirik has extensive experience working with collaborations between academia and industry, and commercialization of research and spin-off companies. He previously held the position as Head of TTO at Norinnova Technology Transfer. Eirik graduated with a PhD in Biotechnology from the UoT The Arctic University of Norway, and has more than 15 years of research within biotechnology and microbiology from Norway and the US.

Klara Stensvåg, Professor
UiT The Arctic University of Tromsø

Presentation: Scientific Workshop Introduction

 

Peter Nichols, Research Scientist
CSIRO, Australia

Presentation: Production and use of single cell oil (SCO) containing Omega-3 fatty acids 

Peter Nichols leads new initiatives with marine biotechnology, signature lipids and their environmental applications, and on marine oils, with particular emphasis on omega-3 oils.  The latter research has involved detailed characterization of fish-derived and novel microbial oils, process development for the utilization of oils, development as part of a wider CSIRO team of novel land plant sources of the health benefitting long-chain omega-3 oils, and transfer and application of these know-how to industry and the wider community. This research has lead to better utilisation of substantial national fisheries resources and wastes, and to new oilseed crops.  He has contributed to the development of the Australian marine oils industry, with CSIRO research resulting in novel national and international marine oil products (wax ester, omega-3 and shark liver oils).  Other innovations have been the development and use of unique chemical (lipid) signatures in microbial ecology, environmental (e.g., fecal pollution) and food-chain studies, and new discoveries and applications in marine microbial biotechnology.  He has worked closely with a number of Australian and overseas Universities including actively supervising and mentoring over 30 postgraduate students. International collaboration has occurred across these research fields, including sponsoring sabbaticals and visits by overseas scholars.   

Asbjørn Lilletun
Norinnova Technology Transfer, Norway

Presentation: How can academia succeed in attracting commercial players into partnership?

Erik Hjelvin, Medical Director
Pfizer, Norway

Presentation: Which demands and expectations does the Pharma industry have towards academia and startup companies?

Erik has been with Pfizer as Medical Director in both Country and Nordic roles since 2010. His main areas of interest are Research and Development, Medical Information, communication and education and Medical strategy. 2006-2010 he worked with GlaxoSmithKline as Head of Medical Affairs in Norway and as Regional Medical Advisor in Urology. As a background, he is a medical doctor, and he was board certified specialist in Anesthesiology and Intensive Care in 1995 and also became European Diplomat in Anesthesiology and Intensive Care the same year. In 2003 he graduated as Master in Health Administration and Health Economy from the University of Oslo. He held different positions of increasing seniority in the national health care system (Hospitals) until 2005.

Trygve Brautaset, Professor
NTNU, Norway

Presentation: System Biology approach in drug discovery – a brief introduction and possibilities 

Brautaset is Professor in synthetic biology at NTNU and before that he was Research Director for Department of Molecular Biology at SINTEF. Brautaset has coordinated two international research projects in synthetic biology; one (SynMet, 2011-2014) funded by the European Science of Foundation and one EU project (PROMYSE, 2012-2015), and is currently coordinator for one ERASysAPP project (MetApp, 2015 – 2017) and for one ERA_MBT project (ThermoFactories, 2016 – 2018). Brautaset is currently also leader of Center for Digital Life Norway which has focus on transdisciplinary research, education and innovation in biotechnology. His main research activities are within microbial molecular biology with particular focus on synthetic biology and systems biology. 

Theresa Comiskey Olsen, Partner
Langseth Lawyers DA, Norway

Presentation: What makes an agreement good? 

Theresa Comiskey Olsen is an American lawyer who has spent most of her career working within pharma/life sciences.  Theresa joined Langseth Law Firm in 2016 after setting up in private practice with a focus on negotiating and drafting of international agreements for pharma/biotech/medtech companies. Prior to this Theresa was General Counsel and Company Secretary for Nycomed.

Leif Rune Skymoen, CEO
Curida AS, Norway

Presentation: How may a pharma factory become a partner in the development of drugs and nutraceuticals?

Leif Rune Skymoen is CEO of the Norwegian Contract Development and Manufacturing Organisation Curida. He has more than 15 years of experience from the medical innovation and international pharmaceutical industry. Skymoen was previously CEO of Nansen Neuroscience Network, an innovation network specializing in neuroscience. Before that he held a series of national and international positions at Eli Lilly & Company, including Country Director for the company’s Norwegian operations. He is currently a board member at Nansen Neuroscience Network and the Association of the Pharmaceutical Industry in Norway (LMI). Skymoen holds a Master of Management from the BI Norwegian School of Business and an MscPharm from the University of Oxford and the University of Oslo.

Bengt Erik Haug, Professor
University of Bergen, Norway

Presentation: Peptidomics approach to refine bioactive peptides to peptidomimetics – a case study 

Bengt Erik Haug holds a PhD in organic chemistry from the University of Tromsø (June of 2002). During his PhD he worked on the design and synthesis of cationic antimicrobial peptides (CAP's) and synthetic antimicrobial peptidomimetics (SAMP's). Before moving to Bergen, he was a post doc in the research group of Professor Daniel H. Rich at the School of PharmacyUniversity of Wisconsin-Madison, USA (2003-2004) and worked as a scientist for Lytix Biopharma AS (2005-2006).

Current research activities include design and synthesis of biologically active peptides and peptidomimetics and synthesis of marine natural products and analogs.

Suzanne Elvidge, MSc
Biopharma and Medical Writer, UK

Presentation: How should the researcher/founder approach the media?

Suzanne has been using the written word for the whole of her 25-year career in journalism, publishing, communications and PR. She has worked freelance for over ten years, and writes about pharmaceutical R&D, consumer healthcare and medicine, and the healthcare, pharmaceutical and biotechnology industries, for industry, science, healthcare professional and patient audiences. Suzanne writes daily pharmaceutical news for BioPharma Dive, and has written features, news and company profiles for a range of publications including Pharmaceutical Journal, Nature Biotechnology and Nature BioPharma Dealmakers, FierceMarkets, Life Science Leader, Start Up, and New Scientist, as in-depth reports and ebooks on a range of industry topics for FirstWord, Datamonitor, and FierceMarkets. She also writes blogs for scientific, business and consumer sites. She also trains people in writing and editing skills, and speaks on science in the media. Suzanne is based in the UK, in the Derbyshire Peak District, where she lives above and co-owns a second-hand bookshop.

Thomas Ramdahl, CEO
Bayer, Norway

Presentation: From idea to business - Algeta - a success story 

Thomas Ramdahl is managing director of Bayer AS. Thomas joined Bayer as a result of Bayer’s acquisition of the pharmaceutical company Algeta ASA, where Thomas was the first CEO and one of the key persons building the company from early start over more than ten years. Before this, Thomas held several management positions in different divisions of Norsk Hydro/Pronova including oil & gas, petrochemicals and pharmaceuticals. He has also worked as a research scientist at the University of California, Riverside and at the Central Institute for Industrial Research, Oslo. He holds an MSc in organic chemistry from the Norwegian Institute of Technology (1979) and a Dr.Philos. in environmental chemistry from the University of Oslo (1984).

Deniz Tasdemir and Peter Nichols

Presentation: Associations of Biotechnology worldwide

Scroll down for Deniz Tasdemir's bio.

Scroll up for Peter Nichol's bio.

All participants
Anne Husebekk, Rector
UiT The Arctic University of Norway

Presentation: The university city of Tromsø

For the last 3.5 years Anne Husbekk has been the Rector of UiT, elected by the faculty, staff and students. She initially came to UiT for medical studies. As a professor of medicine (immunology), Anne is particularly interested in the immunology of the fetal/maternal interface. For 4 years she lived abroad on sabbatical at the National Institute of Health Bethesda, Institute Curie Paris and University of Copenhagen. Aside from her work in Tromsø, she has had both national and international positions related to transfusion medicine and research policy. UiT is the northernmost university of the world, and due to the unique location the university places great focus on Arctic issues in both bioprospecting and biotechnology.

Jeanette Hammer Andersen
Marbio UiT The Arctic University of Norway

Presentation: Success stories involving marine bioactive compounds

Jeanette Hammer Andersen is a professor in marine bioprospecting at UiT- The Arctic University of Norway and head of the natural products platform Marbio at UiT. Marbio has experience in screening extract library of natural product origin, both terrestrial and marine organisms and has successfully identified several novel bioactive compounds. Jeanette Andersen’s research interest and focus is the discovery of novel bioactive compounds from the marine environment.  

Jörg Overmann, Managing Director
Leibniz-Institut DSMZ, Germany

Presentation: Challenges and opportunities of bioprospection through microbial culture collections

Prof. Dr. Jörg Overmann has been the Scientific and Administrative Managing Director of the Leibniz-Institute DSMZ German Collection of Microorganisms and Cell Cultures GmbH since 1 February 2010. Overmann studied Biology with emphasis on microbiology in Bochum and Freiburg. He earned his doctorate in 1991 at the University of Constance upon completing his thesis concerning the site-specific adaptation of sulphur bacteria and received the Doctoral Graduation Award of the Association for General and Applied Microbiology. After finishing a research post in Vancouver, Canada, Overmann qualified as Professor at the Carl von Ossietzky University in Oldenburg in 1999. Shortly thereafter, Overmann received an appointment as Professor for Microbiology at the Ludwig-Maximilians-Universität in Munich.  There he has led the Department of Biology I with the sections Microbiology, Genetics, Botany, Biodiversity and Didactics of Biology since 2003.

Thomas Vanagt, Founder & Director
eCoast, Belgium

Presentation: Access and benefit sharing of marine genetic resources

Thomas Vanagt originally trained as a marine ecologist, obtaining a PhD in benthic ecology from Ghent University in Belgium. He is now the managing director of eCOAST, a marine environmental research centre in Belgium. Over the past few years, Thomas has been working closely with science and industry on Access and Benefit Sharing under the Nagoya Protocol and on MGR in particular. Since 2016 he is the managing director of ABS-int, a company dedicated to unlocking genetic resources.

Steinar Bergseth, Special Advisor/Biotech
The Research Council of Norway

Presentation: The European marine biotechnology research and innovation roadmap

Steinar Bergseth is Special Advisor for biotechnology in the Research Council of Norway. He is involved in all aspects of biotechnological R&D funding and strategic planning in Norway through national and international programs. He coordinated the building of the national functional genomics efforts in Norway from 2002 to 2008 (FUGE). Now he is involved in the national strategy for biotechnology through the BIOTEK2021 program. He has over the last years concentrated mainly on the marine area and how biotechnology can contribute to develop sustainable use of marine resources for food, pharmaceuticals, materials and energy. The overarching goal is to develop marine biotech to be a significant part of a sustainable bioeconomy through involvement in European Union activities and the OECD. He is coordinating the ERA-NET MarineBiotech project (19 partners / 2013–2017). Steinar Bergseth earned his PhD at the University of Oslo, was eight years with a pharmaceutical R&D unit in Nycomed Amersham and did consulting for environmental water issues before he joined the RCN in year 2000.

Hans-Christian Eilertsen, Professor
UiT - The Arctic University of Norway

Presentation: Mass cultivation of northern diatoms: Turning pollution into capital

Hans Chr. Eilertsen is a professor in the fields of microalgae, biotechnology and physical-biological oceanography. He has 40 years of experience in research on the Arctic, northern and tropical marine climates and plankton organisms. His projects are currently aimed at the mass cultivation of omega-3 producing of diatoms while sequestrating CO2 and NOx.

Peter Nichols, Research Scientist
CSIRO, Australia

Presentation: Sustainable sources of health-benefitting long-chain omega-3 oils: A journey from gene discovery to a new oilseed plant – canola-DHA

Peter Nichols leads new initiatives with marine biotechnology, signature lipids and their environmental applications, and on marine oils, with particular emphasis on omega-3 oils.  The latter research has involved detailed characterization of fish-derived and novel microbial oils, process development for the utilization of oils, development as part of a wider CSIRO team of novel land plant sources of the health benefitting long-chain omega-3 oils, and transfer and application of these know-how to industry and the wider community. This research has lead to better utilisation of substantial national fisheries resources and wastes, and to new oilseed crops.  He has contributed to the development of the Australian marine oils industry, with CSIRO research resulting in novel national and international marine oil products (wax ester, omega-3 and shark liver oils).  Other innovations have been the development and use of unique chemical (lipid) signatures in microbial ecology, environmental (e.g., fecal pollution) and food-chain studies, and new discoveries and applications in marine microbial biotechnology.  He has worked closely with a number of Australian and overseas Universities including actively supervising and mentoring over 30 postgraduate students. International collaboration has occurred across these research fields, including sponsoring sabbaticals and visits by overseas scholars.   

Nils Hoem, Chief Scientist
Aker BioMarine, Norway

Presentation: Utilization of biomass of krill: Use and sustainability

Dr. Nils Hoem Chief Scientist Nils Hoem was educated M.Sc. Pharmacy at University of Oslo, Norway, in 1983 and finished a Dr. Philos. in Pharmacology at University of Oslo in 1991. He worked was Associate Professor at University of Oslo until 2000. After working as a visiting scientist at University of Southern California from 2000-2001, he has held Director positions at MDS Pharma Services Europe, Pronova Biopharma Norway and finally joined Aker Biomarine as a Chief Scientist in 2008. Sectors of Personal Expertise: food & beverages / life sciences / chemicals / other industrial products, materials or services

Kurt Tande, Co-Founder/CTO
Calanus, Norway

Presentation: Development of new bioindustry based on Calanus finmarchicus - Possibilities and Challenges

Kurt Tande (born 1951) is CTO and co-founder of Calanus AS. He attained his PhD in marine ecology in 1993, and has served as professor for the University of Tromsø and North University for over 20 years. Kurt has developed an extensive multidisciplinary network within the field of science and has a wealth of professional and administrative experience as a board member for several research programs at the Research Council of Norway.

Poster Presentors: Andrea Bourdelais, Netsanet G. Assefa, and Diana Lindberg

Presentations: 3 Oral Poster Presentations in Exploration of marine biomass

Andrea Bourdelais (University of North Carolina at Wilmington, USA) - Culturable Marine Organism as a Source for Bioactive Compounds

Netsanet G. Assefa (UiT The Arctic University of Norway) - Production of polyhydroxyalkanoate-based bioplastics from marine bacteria

Diana Lindberg (Nofima AS, Norway) - Evaluation the efficiency of commercial inhibitors in preventing blueing in snow crab

Ragnar Olsen, Professor
UiT - The Arctic University of Norway

Keynote Presentation: What are the options for marine biomass when it is not suitable as food?

Professor Ragnar L. Olsen has a PhD in Biochemistry and was appointed professor in marine biochemistry at the Norwegian College of Fishery Science, UiT The Arctic University of Tromsø in 1991. He has also been working at The Norwegian Institute of Food, Fisheries and Aquaculture Research, an applied research institute in Tromsø, Norway. Main areas of research for about 30 years have been seafood quality and utilization of by-products from processing of fish and shellfish. Some of this work has been carried out in cooperation with industry. Altogether, he has published more than 100 scientific publications and supervised about 80 master and PhD students.  

Trygve Brautaset, Professor
NTNU, Norway

Keynote Presentation: Synthetic biology - an important tool for industrial biotechnology

Brautaset is Professor in synthetic biology at NTNU and before that he was Research Director for Department of Molecular Biology at SINTEF. Brautaset has coordinated two international research projects in synthetic biology; one (SynMet, 2011-2014) funded by the European Science of Foundation and one EU project (PROMYSE, 2012-2015), and is currently coordinator for one ERASysAPP project (MetApp, 2015 – 2017) and for one ERA_MBT project (ThermoFactories, 2016 – 2018). Brautaset is currently also leader of Center for Digital Life Norway which has focus on transdisciplinary research, education and innovation in biotechnology. His main research activities are within microbial molecular biology with particular focus on synthetic biology and systems biology. 

Alexander Wentzel, Senior Researcher
SINTEF, Norway

Presentation: New bioactive compounds from environmental microbial resources by an integrated functional (meta)genomics approach

Dr. Wentzel works as a Senior Researcher at SINTEF Materials and Chemistry, Dept. of Biotechnology and Nanomedicine. He studied Biology at the Georg-August-University in Göttingen, Germany, where he also finished his PhD in Molecular Biology in 2003. During his post-doctoral period at NTNU and SINTEF in Trondheim from 2005-2010, he worked on research projects within the fields of microbial upgrading of crude oil (financed by VISTA) and Systems Biology understanding of the metabolic switch to antibiotics production by the model Actinobacterium Streptomyces coelicolor. Dr. Wentzel's current main research focus and interest is on developing efficient tools for accessing the vast biodiversity of microorganisms in nature for the discovery and development of new products for the enzyme and biopharmaceuticals market. Within this field, he currently coordinates the ERA-IB project OXYPOL, the ERASysAPP project SYSTERACT, the Centre for Digital Life Norway project INBioPharm, as well as a SINTEF internal strategic project on Functional Metagenomics. In addition, he is SINTEF PI in several national and European projects, including the Horizon 2020 project MetaFluidics.

Gabrielle Potocki-Veronese, Research Director
INRA, France

Presentation: High-throughput functional metagenomics for the discovery of glycan metabolic pathways

Dr. Potocki-Veronese is a Research Director at the French National Institute for Agricultural Research (INRA). She is a specialist in enzyme discovery through functional metagenomics and in combinatorial protein engineering. Ten years of hard work has resulted in more than 50 publications and patents in the field of enzyme discovery by functional metagenomics, biocatalyst characterisation and use for polymer modification. She leads the thematic group called DiscOmics (“metaomics for enzyme discovery”) in the Laboratory of Engineering of Biological Systems and Processes (LISBP) in Toulouse, France, and has coordinated or participated in 22 national and international projects in these fields. She is currently the LISBP PI in the Horizon 2020 projects MetaFluidics, Zelcor and Catsys.

Poster Presentors: Antonio García-Moyano, Anja Martinez, and Jenny Söderberg

Presentations: 3 Oral Poster Presentations in Synthetic Biology

Antonio García-Moyano (Uni Research, Norway) - Discovery of proteases for bioconversion of marine biomass

Anja Martinez (Thermo Fisher Scientific, Sweden) - Enhanced CRISPR/Cas9-mediated precise genome editing

Jenny M. Söderberg (UiT The Arctic University of Norway) - Development of a novel expression host for challenging enzymes

Syed Asad Rahman; Bio/Chemo Informatician
EMBL-EBI, UK

Presentation: The use of new targeted bioinformatics tools to streamline sequence-based target selection

An experienced, versatile and creative scientist with ~10 years of R&D experience in Computational Biology, Bioinformatics and Chem-informatics in academic and industrial environments. Focused on development of products to improve healthcare through innovation, collaborative and KDD approaches. 

Trond Erik Vee Aune, Founder/CEO
Vectron Biosolutions, Norway

Presentation: Perspectives from the recombinant protein production industry

Trond Erik Vee Aune did his PhD in Professor Svein Valla’s research group at Department of Biotechnology at NTNU, Trondheim, Norway. Aune’s work included directed enzyme evolution, structure and function of transcription regulators, synthetic biology, research into novel transformation methods, and controlled gene expression. He defended his PhD thesis in 2008 with the title “High level recombinant protein production in Escherichia coli by engineering broad-host-range plasmid vectors containing the Pm/xylS expression cassette.” After graduating, Aune and Valla founded the company Vectron Biosolutions. The company objective is to realize the commercial potential in the expression vector technology platform developed in Valla’s research group. Based in Trondheim, the company is offering technology and services to companies across the life science industries who need improved bacterial production processes for their recombinant proteins. Vectron’s main customers are pharmaceutical companies who are producing therapeutic proteins and industrial companies who are producing technical enzymes. The company had a major commercial breakthrough in 2015 with the announcement of a deal with the pharmaceutical giant Boehringer Ingelheim. 

Stuart West, Managing Director
Biocatalysts, UK

Presentation: Enzyme development: From sequence to enzyme in 8 weeks

Stuart started life as a BP sponsored student studying chemistry.  After working for BP as a Technologist for 3 years on Single Cell Protein (SCP) he moved to Leatherhead Food Research Association (now LFI) where he specialised in functional food proteins and food processing enzymes.  It was from here that he was recruited to Biocatalysts as Business Development Manager.  He became Managing Director in 1995 and his truly visionary leadership has led the Company to become the success it is today. Stuart is passionate about the science in Industrial Biotechnology and works closely with many Universities to bring cutting edge science into Biocatalysts. He also describes himself as an “honourable thief” adopting models of good business practice and business excellence from different types of companies from all around the world. He is an active member of the UK’s IBLF (Industrial Biotechnology Leadership Forum). He is also a campaigner to improve the skill levels of scientists coming out of British Universities and is Chairman of the IBLF’s skills group which he runs with Cogent Skills (UK’s strategic body for science skills).  He is also a member of the CBI’s SME council and a Chartered Director of the IOD.

Bert Klebl, CEO/CSO
Lead Discovery Center, Germany

Keynote Presentation: From Research in Marine Bioactives to Pharmaceutical Drug Discovery - The Tromsø to Dortmund Connection

Bert M. Klebl has almost 20 years of professional experience in drug discovery and early drug development from various positions in the life-science industry. Since its initiation in 2008, he has been CEO and CSO of Lead Discovery Center of Germany, a drug discovery enterprise, started by Max-Planck Innovation and the German Max-Planck Society to accelerate technology transfer. Before joining LDC, Bert was the Head of Biology at GPC Biotech in Germany. Prior to that he was the Vice President of Research at Axxima's, responsibility for discovery and development of the company's portfolio of small molecule drug candidates for various therapeutic indications. He also led a global kinase drug discovery platform at Hoechst Marion Roussel and Aventis, working as a team project leader and head of the lab. Bert earned his PhD in Biochemistry at the University of Konstanz Germany and did post-doctoral work at the Biotechnology Research Institute of the National Research Council of Canada. He has published more than 40 articles and is a co-inventor of more than 25 patents and patent applications.

Dagmar Stengel, Senior Lecturer
NUI Galway, Ireland

Presentation: Application of algal biomass

Dr Stengel is a Senior Lecturer and Principal Investigator at the National University of Ireland Galway, with over 25 year experience in algal research. She is Head of Discipline of Botany and Plant Science at NUI Galway, leads the research theme ‘Algal BioSciences’, and serves as Secretary of the European Federation of Phycological Societies. Her research interests include the sustainable utilisation of natural seaweed resources and the optimised cultivation of macro- and microalgal biomass for the production of high value compounds with applications in specific sectors including marine-derived foods/ingredients. She has long-standing experience in the assessment of environmental impacts and stressors on algal biology, productivity and composition (ecophysiology). She has published over 50 peer-reviewed articles, over 200 conference contributions and has received multiple invitations as keynote speaker at international conferences. She recently edited a book on ‘Natural Products from Marine Algae’ published by Springer and is currently engaged in several algal research projects funded by national and European sources, ranging from seaweed resource assessment methodologies to novel extraction technologies for algal compounds with marine biotechnological applications.

Deniz Tasdemir, Professor
GEOMAR, Germany

Presentation: New Approaches for Addressing Oceans' Dark Matters: Cultivability, Structure elucidation and Imaging

Deniz Tasdemir is a full professor at GEOMAR Helmholtz Centre for Ocean Research Kiel (Germany) where she leads the Research Unit Marine Natural Products Chemistry and GEOMAR Centre for Marine Biotechnology (GEOMAR-Biotech). Her research interests include marine natural product discovery (against cancer and infectious diseases) from marine invertebrates, algae and cultivable microbes and chemical ecology. She has a long expertise in analytical/natural products chemistry. She applies metabolomics and molecular networking, OSMAC/co-cultivation and imaging mass spectrometry (DESI-IMS) techniques as research tools. Prof. Tasdemir is the author of over 100 publications, reviews, book chapters and several patents. She serves in the editorial board of several international journals including Planta Medica, Phytochemistry Letters and Marine Drugs. Prof. Tasdemir is the recipient of many distinctions and prestigious awards, e.g. Pierre Fabre Prize (Phytochemical Society of Europe, 2004), Egon-Stahl Silver Medal (Society for Medicinal Plant Research and Natural Products, 2005) and Waters Award for Excellence in Natural Product Innovation (2016). She leads the Interreg BSR project Baltic Blue Biotechnology Alliance and is partner of several other EU projects such as BLUEandGREEN and MarPipe. 

Tim Bugni, Professor
University of Wisconsin - Madison, USA

Presentation: Ecteinamycin, an antibiotic for Clostridium difficile

Tim received his bachelor's degree in chemistry from MT Tech in 1995 and a Ph.D. degree from the University of Utah with Professor Chris M. Ireland. He held a postdoctoral appointment at Scripps Institution of Oceanography (2003-4), and was a research assistant professor at the University of UT from 2004-2009. He joined the faculty at the University of Wisconsin - Madison School of Pharmacy in 2009, where he is currently an associate professor. His research interests include marine natural products chemistry, symbiotic microorganisms, drug discovery, metabolomics, and NMR and MS for structure elucidation of novel natural products. 

Poster Presentors: Tiago Silva, Giovanna Romano, and Pamela Walsh

Presentations: 3 Oral Poster Presentations in Applications of marine natural products

Tiago Silva (Universidade do Minho, Portugal) - A wave moving marine materials up to the biomedical field: engineering different human tissues as high added-value blue biotechnology approach

Giovanna Romano (Stazione Zoologica Anton Dohrn, Italy) - Actiskin: a new cosmeceutical formulation from the green microalga Tetraselmis suecica

Pamela Walsh (Queen's University Belfast, Ireland) - The Osteogenic Potential of Brown Seaweeds Extracts

Deniz Tasdemir, Professor
GEOMAR, Germany

Deniz Tasdemir is a full professor at GEOMAR Helmholtz Centre for Ocean Research Kiel (Germany) where she leads the Research Unit Marine Natural Products Chemistry and GEOMAR Centre for Marine Biotechnology (GEOMAR-Biotech). Her research interests include marine natural product discovery (against cancer and infectious diseases) from marine invertebrates, algae and cultivable microbes and chemical ecology. She has a long expertise in analytical/natural products chemistry. She applies metabolomics and molecular networking, OSMAC/co-cultivation and imaging mass spectrometry (DESI-IMS) techniques as research tools. Prof. Tasdemir is the author of over 100 publications, reviews, book chapters and several patents. She serves in the editorial board of several international journals including Planta Medica, Phytochemistry Letters and Marine Drugs. Prof. Tasdemir is the recipient of many distinctions and prestigious awards, e.g. Pierre Fabre Prize (Phytochemical Society of Europe, 2004), Egon-Stahl Silver Medal (Society for Medicinal Plant Research and Natural Products, 2005) and Waters Award for Excellence in Natural Product Innovation (2016). She leads the Interreg BSR project Baltic Blue Biotechnology Alliance and is partner of several other EU projects such as BLUEandGREEN and MarPipe.